Ontario Mental Health Funding, GLP-1 Trends, and Fasting for Weight Loss
Morning Medical with Dr. Chow
A daily update covering the latest medical & health news from around the world using artificial intelligence. Doctor Chi-Ming Chow is a family physician, general internist, and cardiologist. He is also a Professor of Medicine at the University of Toronto.
Chi-Ming Chow
PodcastAI
PodcastAI

Ontario Mental Health Funding, GLP-1 Trends, and Fasting for Weight Loss

E195 • Apr 1, 2025 • 14 mins

In this episode, Dr. Chi-Ming Chow begins with an overview of mental health services in Ontario, focusing on the challenges of delays and the impact of recent federal investments. He then shifts to the rising expenditure on GLP-1 receptor agonists in the U.S., analyzing the user demographics and implications for healthcare. The episode explores a study comparing intermittent fasting with daily calorie restriction, assessing their effectiveness for weight loss. Dr. Chow also provides insights into factors influencing earthquake survival and offers practical survival tips. The episode concludes with a farewell and a summary of key takeaways.

Key Points

  • Young people in Ontario are facing significant delays in accessing mental health treatment, with wait times now exceeding three months.
  • Spending on GLP-1 receptor agonists among non-diabetic adults in the U.S. surged to $5.8 billion in 2022, driven by increased prescriptions for weight management.
  • Intermittent fasting may be more effective for weight loss than daily calorie restriction, with participants in a recent study losing an average of 6.37 pounds more than those on a daily calorie-restricted diet.
Listen on Apple PodcastsListen on Spotify
- / -